Add to Google
Isolated Protein Domain Linked to Tumors
Friday, February 20, 2009 - Anuradha Menon
Home >> Headlines >> Cancer Research
  Peralink
When a promising cancer drug reached clinical trials in the 1990s, researchers were disappointed by the debilitating side effects that limited the trials. The drug inhibited a family of enzymes known as matrix metalloproteinases (MMPs). Now, researchers at Rensselaer Polytechnic Institute have shown that creating drugs that inactivate a different part of the MMP enzyme could have the capacity to target the tumor without the damaging side effects.    (source: news.rpi.edu)



Related News Slowing Cancer Metabolism Slowing Cancer Metabolism Interferon Based Drug May Eliminate Breast Cancer Interferon Based Drug May Eliminate Breast Cancer

Related Pictures Purple Tomatoes to Fight Cancer Purple Tomatoes to Fight Cancer New Contrast Agent to Help Fight Cancer New Contrast Agent to Help Fight Cancer

Other Articles The Future of Electronic Paper The Future of Electronic Paper 2008 In Technology 2008 In Technology


Terms Of Use | Privacy Policy | Contact Us | Advertise With Us | Site Profile
Copyright © 2011 The Future of Things. All rights reserved.
Feedback Form